Azurity Pharmaceuticals: all 78 studies

Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.

• Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal MenNot yet recruitingNCT07328542Phase 4
• Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset SeizuresNot yet recruitingNCT06534502Phase 4
• A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric SubjectsRecruitingNCT03893045Phase 3
• A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)RecruitingNCT03619850Phase 3
• Abuse Potential of HORIZANT With and Without Oxycodone in Healthy, Nondependent Recreational Opioid UsersCompletedNCT06247488Phase 4Results posted
• An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug UsersCompletedNCT06097676Phase 4Results posted
• Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy AdultsTerminatedNCT04593784Phase 2Results posted
• Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine SulfateCompletedNCT03659929Phase 3Results posted
• Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCTCompletedNCT03288454Phase 2Results posted
• Phase 2 Study of Rivaroxaban Reversal by Ciraparantag as Measured by WBCTCompletedNCT03172910Phase 2Results posted
• Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe PreeclampsiaTerminatedNCT03008616Phase 2/3Results posted
• Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal WomenCompletedNCT02940522Phase 1Results posted
• Study Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal WomenTerminatedNCT02937766Phase 3Results posted
• A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)CompletedNCT02694978Phase 3Results posted
• An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With HypertensionCompletedNCT02235909Phase 3Results posted
• Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom SettingCompletedNCT01986062Phase 4Results posted
• Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment StudyCompletedNCT01668667Phase 4Results posted
• Simulated Driving Study in Restless Legs SyndromeCompletedNCT01332318Phase 2Results posted
• Dose-Response and Pharmacokinetics of Gabapentin Enacarbil (GEn [XP13512 / GSK1838262]) in Restless Legs SyndromeCompletedNCT01332305Phase 2Results posted
• A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney DiseaseTerminatedNCT01264679Phase 3Results posted
• Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on HemodialysisCompletedNCT01227616Phase 4Results posted
• A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney DiseaseTerminatedNCT01155388Phase 3Results posted
• A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney DiseaseTerminatedNCT01155375Phase 3Results posted
• A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency AnemiaCompletedNCT01114217Phase 3Results posted
• A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency AnemiaCompletedNCT01114204Phase 3Results posted
• A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency AnemiaCompletedNCT01114139Phase 3Results posted
• A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney DiseaseCompletedNCT01052779Phase 2Results posted
• Confirmatory Study of 17P vs Vehicle for Prevention of Preterm Birth in Women w/ Previous Spontaneous Preterm DeliveryCompletedNCT01004029Phase 3Results posted
• Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep DisturbanceCompletedNCT00748098Phase 3Results posted
• Prevention Study in Adult Patients Suffering From Migraine HeadachesCompletedNCT00742209Phase 2Results posted
• Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)CompletedNCT00707876Phase 2Results posted
• A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)CompletedNCT00643760Phase 2Results posted
• A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)CompletedNCT00619476Phase 2Results posted
• A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin TreatmentCompletedNCT00617461Phase 2Results posted
• XP13512 vs. Placebo in Patients With Restless Legs Syndrome.CompletedNCT00365352Phase 3Results posted
• XP13512 (Gabapentin Enacarbil) Extension Study in Patients With Restless Legs Syndrome.CompletedNCT00333359Phase 3Results posted
• Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.CompletedNCT00311363Phase 3Results posted
• Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With ZofranCompletedNCT03973047Phase 1
• Variability of Whole Blood Clotting Time Measurements in Ex Vivo Human Blood Samples Spiked With AnticoagulantsCompletedNCT03296982
• Relative Bioavailability of AR10 Compared to Reference ProductCompletedNCT02723669Phase 1
• Vigilant ObservatIon of GlIadeL WAfer ImplaNT RegistryCompletedNCT02684838
• An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLSStatus unknownNCT02633683Phase 4
• A PK and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLSWithdrawnNCT02633657Phase 1
• An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLSStatus unknownNCT02560766Phase 4
• Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil TabletsCompletedNCT02522208Phase 1
• Study of PER977 Administered to Subjects With Steady State Edoxaban Dosing and Re-anticoagulation With EdoxabanCompletedNCT02207257Phase 2
• Variability in the Measurement of WBCT Between Blood Drawn From Indwelling Catheters and Direct VenipunctureCompletedNCT02207205Not applicable
• Pharmacokinetics of Ultra-Rapid-Acting Insulin Lispro (URAL) in Type 1 Diabetes MellitusWithdrawnNCT02206568Phase 1
• PK and PD of Single, Escalating Doses of PER977 Following EnoxaparinCompletedNCT02206100Phase 1/2
• Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PER977 Following HeparinCompletedNCT02206087Phase 1/2
• An Open-label, Single-dose, Non-randomized Study of IV 14C-labeled PER977 in Healthy Male SubjectsCompletedNCT02205905Phase 1
• A Study to Determine the Inter/Intra Observer and Intra-subject Variability of Whole Blood Clotting Time MeasurementsCompletedNCT02205827Not applicable
• Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007)TerminatedNCT02074007Phase 3
• Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)TerminatedNCT02049164Phase 2
• Phase 3 Study to Compare the Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis MediaCompletedNCT02044341Phase 3
• Phase I Rising-dose Study to Assess Tolerability, Safety, Pharmacokinetics, Pharmacodynamics of AR09TerminatedNCT02027155Phase 1
• AR08 for Treatment of ADHD in ChildrenCompletedNCT01876719Phase 2
• Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of EdoxabanCompletedNCT01826266Phase 1
• Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis MediaCompletedNCT01588535Phase 2
• A Comparison of Various Combinations of BiDil Capsules and BiDil Tablets in Healthy Human VolunteersCompletedNCT01587313Phase 1
• A Study to Evaluate the Effect of Gabapentin on Cardiac Repolarization in Healthy VolunteersCompletedNCT01516372Phase 1
• Drug Drug Interaction Study With Gabapentin Enacarbil and MorphineCompletedNCT01476124Phase 1
• Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy SubjectsCompletedNCT01411124Phase 1
• Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple SclerosisCompletedNCT01359566Phase 3
• A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease SubjectsCompletedNCT01171313Phase 2
• A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm BirthCompletedNCT01146990
• A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)CompletedNCT00978016Phase 2
• An Exploratory Study of XP21279 (With Lodosyn®) and Sinemet® in Parkinson's Disease SubjectsCompletedNCT00914602Phase 1/2
• Relative Bioavailability Study for GSK1838262 (Gabapentin Enacarbil)CompletedNCT00833391Phase 1
• A Study to Evaluate the Safety and Tolerability of Arbaclofen Placarbil (XP19986) in Subjects With Acute Back SpasmsCompletedNCT00817986Phase 2
• A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord InjuryCompletedNCT00557973Phase 2
• An Efficacy and Safety Study of XP19986 in Subjects With Symptomatic GERDCompletedNCT00557401Phase 2
• A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and WomenCompletedNCT00360425Phase 1
• XP13512 (GSK1838262) Versus Placebo in Patients With Restless Legs Syndrome.CompletedNCT00298623Phase 3
• A Crossover Safety Study of Ferumoxytol Versus PlaceboCompletedNCT00255450Phase 3
• Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease PatientsCompletedNCT00255437Phase 3
• Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease PatientsCompletedNCT00255424Phase 3
• Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis PatientsCompletedNCT00233597Phase 3

← Azurity Pharmaceuticals overview and focus areas